Cargando…
Ceftriaxone-Induced Neutropenia Successfully Treated With Alternative β-Lactam Antibiotics: A Case Report and Review of the Literature
Ceftriaxone-induced neutropenia is a rare and severe adverse effect of the drug. It usually resolves in one to three weeks following the cessation of ceftriaxone and the administration of granulocyte colony-stimulating factor (G-CSF). After neutrophil recovery, patients are often treated with non-β-...
Autores principales: | Satake, Kana, Iijima, Kenta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276520/ https://www.ncbi.nlm.nih.gov/pubmed/37332438 http://dx.doi.org/10.7759/cureus.39176 |
Ejemplares similares
-
Ceftriaxone-Induced Thrombotic Thrombocytopenic Purpura Treated Successfully With Plasmapheresis and Eculizumab: A Rare Case Report
por: Qureshi, Zaheer A, et al.
Publicado: (2023) -
Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review
por: Yimer, Ebrahim M., et al.
Publicado: (2019) -
Ceftriaxone-Associated Severe Acute Hepatitis
por: Asif, Muhammad, et al.
Publicado: (2023) -
A Case of Confirmed Ceftriaxone-induced Immune Thrombocytopenia
por: Piedra Abusharar, Shady, et al.
Publicado: (2019) -
Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
por: Naeem, Muhammad, et al.
Publicado: (2021)